Literature DB >> 32246971

Opioid prescribing in adults with and without psoriasis.

Megan H Noe1, Daniel B Shin2, Mackenzie R Wehner3, David J Margolis4, Joel M Gelfand4.   

Abstract

Entities:  

Year:  2020        PMID： 32246971      PMCID： PMC7529723          DOI： 10.1016/j.jaad.2020.03.080

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  MMWR Recomm Rep       Date:  2016-03-18

2.  Chronic Opioid Use in Rheumatoid Arthritis: Prevalence and Predictors.

Authors:  Yvonne C Lee; Joel Kremer; Hongshu Guan; Jeffrey Greenberg; Daniel H Solomon
Journal:  Arthritis Rheumatol       Date:  2019-03-06       Impact factor: 10.995

3.  Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study.

Authors:  Sarah K Chen; Candace H Feldman; Gregory Brill; Yvonne C Lee; Rishi J Desai; Seoyoung C Kim
Journal:  BMJ Open       Date:  2019-06-19       Impact factor: 2.692

4.  Incidence of Long-term Opioid Use Among Opioid-Naive Patients With Hidradenitis Suppurativa in the United States.

Authors:  Sarah Reddy; Lauren A V Orenstein; Andrew Strunk; Amit Garg
Journal:  JAMA Dermatol       Date:  2019-11-01       Impact factor: 10.282
  4 in total
  4 in total

Review 1.  Review of publications evaluating opioid use in patients with inflammatory rheumatic disease.

Authors:  Christine Anastasiou; Jinoos Yazdany
Journal:  Curr Opin Rheumatol       Date:  2022-03-01       Impact factor: 5.006

2.  Trends in opioid prescribing at outpatient visits for psoriasis and psoriatic arthritis.

Authors:  M T Taylor; M H Noe; D B Horton; J S Barbieri
Journal:  Br J Dermatol       Date:  2021-03-18       Impact factor: 11.113

3.  Sex Differences in the Patterns of Systemic Agent use Among Patients With Psoriasis: A Retrospective Cohort Study in Quebec, Canada.

Authors:  Raymond Milan; Jacques LeLorier; Marie-Josée Brouillette; Anne Holbrook; Ivan V Litvinov; Elham Rahme
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

4.  Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis.

Authors:  Sang Hoon Lee; Raquel Tonello; Sang-Taek Im; Hawon Jeon; Jeongsu Park; Zachary Ford; Steve Davidson; Yong Ho Kim; Chul-Kyu Park; Temugin Berta
Journal:  Theranostics       Date:  2020-10-26       Impact factor: 11.556
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.